C. Emmanuel

发表

SYNERGISTIC INDUCTION OF APOPTOSIS IN HUMAN ENDOTHELIAL CELLS BY TUMOUR NECROSIS FACTOR-α AND TRANSFORMING GROWTH FACTOR-β

H. Zoellner, H. Medbury, A. Comis, 2002 .

MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

A. deFazio, N. Hacker, B. Gloss, 2010, BMC Cancer.

Ultrastructural Changes in Endothelium during Apoptosis Indicate Low Microembolic Potential

Wei Xu, H. Zoellner, R. Boadle, 2005, Journal of Vascular Research.

TNF-α and TGF-β synergistically stimulate elongation of human endothelial cells without transdifferentiation to smooth muscle cell phenotype.

H. Zoellner, C. Emmanuel, J. Matthews, 2013, Cytokine.

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer

Dale W. Garsed, Gisela Mir Arnau, V. Gebski, 2017, Clinical Cancer Research.

ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

Joshy George, Keitaro Matsuo, Ignace Vergote, 2014, Journal of the National Cancer Institute.

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.

J. George, S. Fox, S. Fereday, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival in patients with BRCA mutation-positive platinum-sensitive recurrent ovarian cancer.

S. Fereday, A. deFazio, D. Bowtell, 2014 .

Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver

J. George, D. Etemadmoghadam, S. Fereday, 2014, Clinical Cancer Research.

Biology of Human Tumors Genomic Classi fi cation of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP 53-Mutant Tumors and Identi fi es NRAS as an Oncogenic Driver

J. George, D. Etemadmoghadam, S. Fereday, 2014 .

Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis

J. George, D. Etemadmoghadam, A. deFazio, 2011, PloS one.

Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis

A. deFazio, Y. Lei, B. Henderson, 2014, Oncogene.

ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.

M. Beckmann, P. Fasching, R. Vierkant, 2013, Gynecologic oncology.

Induction of contact‐dependent endothelial apoptosis by osteosarcoma cells suggests a role for endothelial cell apoptosis in blood‐borne metastasis

H. Zoellner, H. Medbury, C. Emmanuel, 2003, The Journal of pathology.

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

K. Byth, S. Fox, S. Lade, 2014, Scientific Reports.

Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer

C. Ford, A. de Fazio, C. Ford, 2017, Translational oncology.

Synergistic induction of apoptosis in human endothelial cells by tumour necrosis factor-alpha and transforming growth factor-beta.

H. Zoellner, H. Medbury, A. Comis, 2002, Cytokine.

Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.

N. Traficante, S. Fereday, A. deFazio, 2018, Gynecologic oncology.